These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 9934362

  • 1. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM, Martelli CM, Morais-Neto OL, Martelli P, Costa MB, de Andrade AL.
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S, Bobin P, Brethes B, Huerre M, Moreau JP, Bach MA.
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ, Ohashi DK, Ohkawa S, Walsh GP, Meyers WM, Brennan PJ, Trygg C.
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA, Wallach D, Flageul B, Hoffenbach A, Cottenot F.
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S, Harboe M, Bergsvik H, Brennan PJ.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O, Kumar A, Nigam A, Franken KL, Ottenhoff TH.
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [Abstract] [Full Text] [Related]

  • 17. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
    Agis F, Schlich P, Cartel JL, Guidi C, Bach MA.
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
    [Abstract] [Full Text] [Related]

  • 18. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
    Cartel JL, Chanteau S, Boutin JP, Plichart R, Richez P, Roux JF, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):512-7. PubMed ID: 2205686
    [Abstract] [Full Text] [Related]

  • 19. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ, Draper P, Payne SN, Rees RJ.
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
    Douglas JT, Steven LM, Hirsch DS, Fujiwara T, Nelson KE, Madarang MG, Cellona RV.
    Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.